PVCT Provectus Biopharmaceuticals, Inc.

Fundamentals / CIK 0000315545 / USD

Provectus Biopharmaceuticals, Inc. reported $336K in revenue and a net loss of $4.70M for the fiscal year ended December 31, 2025 (down 45.5% year over year), with a -1344.3% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PVCT in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$3.55M$1.78M$0-$22.92MFY 2016 Net Income: -$24.43M2016FY 2017 Net Income: -$13.52M2017FY 2018 Net Income: -$8.15M2018FY 2019 Net Income: -$6.92M2019FY 2020 Net Income: -$6.68M2020FY 2021 Net Income: -$5.54M2021FY 2022 Revenue: $989KFY 2022 Net Income: -$3.55M2022FY 2023 Revenue: $558KFY 2023 Net Income: -$3.10M2023FY 2024 Revenue: $617KFY 2024 Net Income: -$4.73M2024FY 2025 Revenue: $336KFY 2025 Net Income: -$5.43M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $336K $617K $558K $989K -- -- -- -- -- --
Research & Development $1.90M $2.05M $1.75M $2.39M $2.61M $2.81M $4.00M $4.75M $8.20M $8.21M
Total Operating Expenses $5.63M $5.15M $3.46M $4.42M $4.67M $4.96M $6.30M $8.05M -- --
Operating Income -$5.29M -$4.53M -$2.90M -$3.43M -$4.67M -$4.96M -$6.30M -$8.05M -$13.32M -$24.51M
EBITDA -$5.29M -$4.53M -$2.89M -$3.42M -$4.66M -$4.72M -$5.61M -$7.37M -$12.63M -$23.83M
Interest Income -- -- -- -- $4 $3.4K $23K $20K $31K $2.1K
Interest Expense $5.3K $14K $5.7K $3.4K $962K $1.75M $1.46M $970K -- --
Income Before Tax -$5.51M -$4.77M -$3.10M -$3.55M -$5.54M -$6.68M -$6.92M -$8.15M -$13.52M --
Income Tax Expense -- -- -- -- -- -- -- -- -- $0
Net Income -$5.43M -$4.73M -$3.10M -$3.55M -$5.54M -$6.68M -$6.92M -$8.15M -$13.52M -$24.43M
Basic EPS -$0.01 -$0.01 -$0.01 -$0.01 -$0.01 -$0.02 -$0.02 -$0.02 -$0.04 -$0.12
Diluted EPS -$0.01 -$0.01 -$0.01 -$0.01 -$0.01 -$0.02 -$0.02 -$0.02 -$0.04 -$0.12
Basic Shares Outstanding 420.3M 419.8M 419.5M 419.5M 408.2M 393.3M 386.6M 382.3M 369.2M 233.8M
Diluted Shares Outstanding 420.3M 419.8M 419.5M 419.5M 408.2M 393.3M 386.6M 382.3M 369.2M 233.8M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- -- -- $0 $0 $57K $279K $14K
Research & Development $240K $131K $333K $268K $346K $881K $403K $608K
Total Operating Expenses $1.21M $939K $1.25M $1.12M $1.28M $1.86M $1.38M $2.35M
Operating Income -$1.21M -$939K -$1.25M -$1.12M -$1.28M -$1.80M -$1.10M -$2.33M
EBITDA -$1.21M -$938K -$1.25M -$1.12M -$1.28M -$1.80M -$1.10M -$2.33M
Interest Expense $62K $50K $53K -- $48K $51K $64K --
Net Income -$1.27M -$983K -$1.29M -$1.17M -$1.31M -$1.81M -$1.14M -$2.37M
Basic EPS $0.00 $0.00 $0.00 -- $0.00 $0.00 $0.00 --
Diluted EPS $0.00 $0.00 $0.00 -- $0.00 $0.00 $0.00 --
Basic Shares Outstanding 420.3M 420.3M 420.3M -- 420.3M 420.3M 420.3M --
Diluted Shares Outstanding 420.3M 420.3M 420.3M -- 420.3M 420.3M 420.3M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $251K $307K $77K $22K $683K $97K $591K $51K $106K $1.17M
Cash & Short-Term Investments $251K $307K $77K $22K $683K $97K $591K $51K $106K $1.17M
Accounts Receivable, Net -- -- $476 $394 $5.1K $3.9K $55K $595K -- --
Other Current Assets $71K $236K -- -- -- -- -- -- -- $361K
Total Current Assets $568K $977K $1.36M $1.90M $3.44M $424K $996K $1.02M $958K $1.83M
Property, Plant & Equipment, Net $3.0K $4.9K $12K $21K $32K $45K $58K $72K $87K $72K
Intangible Assets -- -- -- -- -- -- $228K $899K $1.57M $2.24M
Total Non-Current Assets $130K $29K $84K $138K $71K $166K $481K $972K $2.48M $3.78M
Total Assets $698K $1.01M $1.45M $2.04M $3.51M $589K $1.48M $1.99M $3.44M $5.61M
Accounts Payable $716K $1.11M $1.68M $2.09M $1.29M $957K $1.13M $3.31M $3.27M $1.92M
Deferred Revenue (Current) -- $336K $953K $1.51M $2.50M -- -- -- -- --
Total Current Liabilities $6.90M $6.98M $9.02M $8.19M $7.70M $30.71M $3.02M $4.10M $3.60M $2.14M
Total Non-Current Liabilities $103K $0 $25K $73K $0 $84K $22.53M $15.30M $9.86M $0
Total Liabilities $7.00M $6.98M $9.04M $8.27M $7.70M $30.80M $25.55M $19.41M $13.46M $2.14M
Total Debt (incl. Leases) $127K $25K $73K $118K $46K $129K $207K -- -- --
Common Stock $420K $420K $420K $419K $419K $399K $390K $385K $371K $365K
Retained Earnings -$262.9M -$257.4M -$252.7M -$249.6M -$246.0M -$240.5M -$233.8M -$226.9M -$218.7M -$205.2M
Accumulated Other Comp. Income -$60K -$61K -$60K -$36K -$34K -$34K -$24K -- -- --
Total Stockholders' Equity -$6.30M -$5.96M -$7.59M -$6.23M -$4.19M -$30.21M -$24.07M -$17.42M -$10.02M $3.47M
Total Equity -$6.30M -$5.97M -$7.59M -$6.23M -$4.19M -$30.21M -$24.07M -$17.42M -$10.02M $3.47M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $181K $1.16M $224K $251K $72K $386K $390K $307K
Cash & Short-Term Investments $181K $1.16M $224K $251K $72K $386K $390K $307K
Other Current Assets -- -- -- $71K $91K $2.8K -- $236K
Total Current Assets $375K $1.37M $460K $568K $278K $568K $649K $977K
Property, Plant & Equipment, Net $1.6K $2.1K $2.5K $3.0K $3.5K $3.9K $4.4K $4.9K
Total Non-Current Assets $92K $105K $117K $130K $142K $154K $17K $29K
Total Assets $467K $1.47M $578K $698K $420K $722K $666K $1.01M
Accounts Payable $604K $932K $815K $716K $1.18M $1.31M $744K $1.11M
Deferred Revenue (Current) -- -- -- -- -- -- $57K $336K
Total Current Liabilities $7.11M $7.71M $7.24M $6.90M $6.47M $6.49M $5.74M $6.98M
Total Non-Current Liabilities $41K $54K $67K $103K $115K $104K $0 $0
Total Liabilities $7.15M $7.76M $7.31M $7.00M $6.59M $6.60M $5.74M $6.98M
Total Debt (incl. Leases) $92K $104K $116K $127K $139K $150K $13K $25K
Common Stock $420K $420K $420K $420K $420K $420K $420K $420K
Retained Earnings -$266.4M -$265.1M -$264.1M -$262.9M -$261.7M -$260.4M -$258.6M -$257.4M
Accumulated Other Comp. Income -$60K -$60K -$60K -$60K -$60K -$60K -$61K -$61K
Total Stockholders' Equity -$6.66M -$6.28M -$6.72M -$6.30M -$6.15M -$5.87M -$5.10M -$5.96M
Total Equity -$6.68M -$6.29M -$6.73M -$6.30M -$6.17M -$5.87M -$5.07M -$5.97M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$5.51M -$4.76M -$3.10M -$3.55M -$5.54M -$6.68M -$6.92M -$8.15M -$13.52M -$24.43M
Depreciation & Amortization $1.9K $7.2K $8.9K $11K $13K $242K $685K $685K $687K $684K
Stock-Based Compensation $1.24M $1.28M $2.9K $3.0K $24K $135K $23K $80K -- $0
Change in Receivables -- $476 -$82 $4.5K -$1.4K $50K $4.9K $528K $217K $518K
Change in Payables -$390K -$569K -$418K $807K $331K -$170K -$2.19M $42K $1.80M $33K
Operating Cash Flow -$3.33M -$3.28M -$2.57M -$3.04M -$1.01M -$4.09M -$6.19M -$5.20M -$10.35M -$21.94M
Capital Expenditure -- -- -- -- -- -- -- -- -$30K --
Free Cash Flow -- -- -- -- -- -- -- -- -$10.38M --
Investing Cash Flow -- -- -- -- -- -- -- -- -$30K --
Financing Cash Flow $3.09M $2.75M $2.19M $1.37M $4.02M $3.60M $6.75M $5.15M $9.32M $8.92M
Net Change in Cash -$238K -$537K -$405K -$1.68M $3.01M -$493K $540K -$55K -$1.06M -$13.01M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$1.27M -$989K -$1.30M -$1.17M -$1.32M -$1.85M -$1.16M -$2.40M
Depreciation & Amortization $465 $466 $466 $465 $466 $465 $467 $466
Stock-Based Compensation $309K $306K $306K $288K $313K $322K $315K $331K
Change in Receivables -- -- -- -- -- -- -- $11
Change in Payables -$328K $117K $99K -$462K -$133K $567K -$363K -$274K
Operating Cash Flow -$860K -$358K -$358K -$870K -$840K -$523K -$1.09M -$912K
Common Stock Issued $0 $0 $75K -- $0 $0 $700K --
Financing Cash Flow -$117K $1.29M $330K $1.05M $496K $470K $1.07M $788K
Net Change in Cash -$976K $933K -$27K $179K -$344K -$53K -$20K -$124K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -1575.3% -734.4% -520.2% -346.6% -- -- -- -- -- --
Net Profit Margin -1615.8% -766.9% -556.2% -359.4% -- -- -- -- -- --
Return on Equity (ROE) -- -- -- -- -- -- -- -- -- -704.1%
Return on Assets (ROA) -778.6% -470.3% -214.1% -174.5% -157.7% -1133.3% -468.7% -410.1% -393.4% -435.3%
Current Ratio 0.08x 0.14x 0.15x 0.23x 0.45x 0.01x 0.33x 0.25x 0.27x 0.85x
Quick Ratio 0.04x 0.04x 0.01x 0.00x 0.09x 0.00x 0.21x 0.16x 0.03x 0.54x
Revenue Growth (YoY) -45.5% +10.7% -43.6% -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -- -- -- -1575.3% -1857.3% -1344.9% -788.1% -734.4%
Net Profit Margin -- -- -- -1615.8% -1892.8% -1376.9% -816.3% -766.9%
Return on Assets (ROA) -1007.2% -322.3% -966.3% -778.6% -1579.7% -877.1% -805.8% -470.3%
Current Ratio 0.05x 0.18x 0.06x 0.08x 0.04x 0.09x 0.11x 0.14x
Quick Ratio 0.03x 0.15x 0.03x 0.04x 0.01x 0.06x 0.07x 0.04x
Revenue Growth (YoY) -- -- -- -100.0% -100.0% -77.5% +17.0% -88.2%
Source: SEC EDGAR CompanyFacts (CIK 0000315545) · from April 23, 2002 Data through September 30, 2026 · synced Nov 21, 2026, 05:03 UTC · Open in terminal